SynthesisClinical rheumatology2018

Baricitinib, a Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials.

Sumit Kunwar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.